VP, New Ventures, Asset Selection
TLDR
Source novel drug development ideas, analyze assets across scientific and commercial verticals, and convert opportunities into NewCos.
Vice President – New Ventures, Asset Selection
RTW Investments
RTW Investments, LP (“RTW”) is a global, full life-cycle investment and innovation firm dedicated to solving the most challenging, unmet patient needs. We are focused on company building and identifying transformational and disruptive innovations across the biopharmaceutical and medical technologies sectors. Our investment philosophy combines a deep understanding of disease, biology, medicine, and technology with a comprehensive view of commercial opportunities and challenges. Our talented team brings hands-on expertise in targeted areas of innovation, dedicated to the diligent exploration and support of emerging breakthroughs in both industry and academia.
Our mission is simple: we power breakthrough therapies that transform the lives of millions.
RTW Investments – Recent Press
Role Overview
The Vice President will work with the Managing Director and New Ventures team to identify and evaluation opportunities for company creation. The Vice President will be responsible for developing investment theses for drug acquisition targets within given therapeutic area(s).
This position is full-time and reports to the Managing Director, New Ventures.
Key Responsibilities
- Source and maintain a pipeline of novel drug development ideas for NewCos within given therapeutic area(s)
- Conduct proprietary research to analyze assets across science, disease, commercial, IP, CMC, clin dev, regulatory, and valuation verticals.
- Write, pitch, and maintain investment notes for company ideas.
- Build pitch deck including recommended deal terms, clinical development, and financing
- Develop expertise within therapeutic area(s) of coverage
- Attend all relevant medical, banking and partnering conferences
- Convert ideas into NewCos with successful PnL
Qualifications and Skills
- Bachelor’s degree required, Advanced degree (MD or PhD) strongly preferred. All applicants MUST have a degree in and a strong understanding of biological sciences.
- 5+ years of experience focused on the biotech/pharmaceutical sector, buy-side role preferred
- Also open to MD/PhDs with <5 years of experience who are looking to make a career switch
- Ability to operate independently on both strategic and tactical tasks, and clearly articulate the process involved
- Investor mindset, deep experience with producing research notes
- Relevant academic or industry experience in the life sciences is preferred
- Excellent written and verbal communication skills
- Demonstrated tenacity in conducting detailed research and presenting findings
- New York based with willingness to travel (15%)
The duties and responsibilities described are not a comprehensive list and additional tasks may be assigned to the employee from time to time.
Compensation & Benefits
- Comprehensive medical, dental, and vision benefits
- Healthcare concierge service
- FSA and HSA savings plans
- 401(k) plan and company match
- Employee Assistance Program (EAP)
- Corporate fitness and wellbeing benefit (Gympass)
- Pretax commuter benefits
The total compensation for this role includes a base salary, competitive bonus structure, and comprehensive benefits. The target annual cash compensation range is $425,000+, though will be determined by a variety of factors including prior experience, relevant expertise, and the scope of responsibilities assigned.
Benefits
Equity Compensation
401(k) plan and company match
Health Insurance
FSA and HSA savings plans
Paid Time Off
Pretax commuter benefits
Wellness Stipend
Corporate fitness and wellbeing benefit (Gympass)
RTW Investments is a global, full life-cycle investment firm that specializes in tackling significant unmet patient needs through company building and innovation in the biopharmaceutical and medical technology sectors. By blending deep industry expertise with strategic insights, we focus on nurturing disruptive breakthroughs that enhance patient care and transform healthcare outcomes.
- Employees
- 51-200 employees
- Industry
- Capital Markets